ALX Oncology (ALXO.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov9

ALX Oncology Reports Strong Clinical Results in Q3 Earnings Call

00:26

Nov7

ALX Oncology released FY2025 9 Months Earnings on November 7 Pre-Market EST with actual revenue of USD 0 and EPS of USD -1.4751

14:30

ALX Oncology released FY2025 Q3 earnings on November 7 Pre-Market (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4133 (forecast USD -0.3725)

14:30

Oct31

ALX Oncology to Release FY2025 Q3 Earnings on November 7, 2025 Pre-Market EST, Forecast EPS -0.3725 USD

00:11

Oct23

ALX Oncology Holdings Initiates Phase I Clinical Trial of ALX2004

16:30

Aug12

ALX Oncology released FY2025 Q2 earnings on August 12 After-Market EST, actual revenue USD 0 (forecast USD 0), actual EPS USD -0.4855 (forecast USD -0.4506)

23:00